Pathstone Family Office’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$667K Buy
9,646
+3,504
+57% +$250K 0.01% 891
2023
Q2
$446K Buy
6,142
+1,125
+22% +$76K 0.01% 798
2023
Q1
$363K Sell
5,017
-672
-12% -$51.4K 0.01% 829
2022
Q4
$383K Buy
5,689
+1,116
+24% +$80K 0.01% 820
2022
Q3
$300K Sell
4,573
-617
-12% -$47.2K 0.01% 917
2022
Q2
$366K Buy
5,190
+743
+17% +$59.8K 0.01% 702
2022
Q1
$409K Sell
4,447
-705
-14% -$66.2K 0.01% 625
2021
Q4
$521K Buy
5,152
+16
+0.3% +$1.63K 0.01% 546
2021
Q3
$499K Buy
5,136
+1,012
+25% +$102K 0.01% 514
2021
Q2
$425K Buy
4,124
+1,062
+35% +$108K 0.01% 528
2021
Q1
$272K Buy
+3,062
New +$283K 0.01% 514
2018
Q2
– Sell
-15
Closed -$2K – 195
2018
Q1
$2K Buy
+15
New +$1.74K ﹤0.01% 319

Other funds holding CRI

Pathstone Family Office's CRI Position: Q3 2023 in Review

Pathstone Family Office increased its Carter's (CRI) stake by 57% in Q3 2023, buying an estimated $250K and bringing the position to 9,646 shares worth $667K. The position accounts for 0.01% of the portfolio, ranked #891.

Pathstone Family Office first reported a position in CRI in Q1 2018 and has held it in 12 quarters since. 301 funds tracked by Wall St. Rank hold CRI as of Q3 2023.

  • Pathstone Family Office held 9,646 shares of Carter's worth $667K as of Q3 2023.
  • Pathstone Family Office bought 3,504 Carter's shares in Q3 2023, an estimated $250K.
  • Carter's made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #891 holding.
  • Pathstone Family Office first reported a position in Carter's in Q1 2018 and has held it in 12 quarters since.
  • 301 funds tracked by Wall St. Rank held Carter's as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.